FIELD: chemistry.
SUBSTANCE: invention describes a compound of the formula I or its pharmaceutically acceptable salt, where: Q is -NH- or -O-; W is C-R4; X is CH; R1 is 5-6-membered aryl ring with 1-3 nitrogen atoms, where: R1 is substituted by 0-3 groups selected independently out of R, oxo, or OR'; each R' is selected independently out of hydrogen atom or C1-4aliphatic group; R2 is selected out of hydrogen atom or C1-3aliphatic group; R3 is selected out of C(O)NHR, C(O)N(R)2, C(O)R, CO2R, C(R')=NOR or C(R')=NOH; each R is selected independently out of T-Ar or C1-6aliphatic group, where: the said C1-6aliphatic group is substituted by 0-3 groups selected independently out of R' or OR'; T is (CH2)y, where y is 0, 1 or 2; Ar is selected out of: (a) 3-8-membered saturated, non-saturated or aryl ring; (b) 3-7-membered heterocyclic ring with 1-3 nitrogen atoms; or (c) 5-6-membered heteroaryl ring with 1-3 nitrogen atoms, where: Ar is substituted by 0-3 R' groups; and R4 is selected out of hydrogen or fluorine atoms. The invention also describes a composition for bacterial gyrase or toposiomerase IV activity inhibition, method of bacterial gyrase or toposiomerase IV activity inhibition, method of bacteria quantity reduction for patients suffering from nosocomial and non-nosocomial bacterial infections. The invention also concerns a method of obtaining the claimed compounds.
EFFECT: obtaining new compounds with useful biological properties.
23 cl, 4 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
GYRASE INHIBITORS AND APPLICATION THEREOF | 2004 |
|
RU2350612C2 |
INHIBITORS OF BACTERIAL GYRASE AND THEIR APPLYING | 2001 |
|
RU2262932C2 |
CDK4/6 INHIBITOR | 2017 |
|
RU2747311C2 |
PYRIDOPYRIMIDINE INHIBITORS CDK2/4/6 | 2017 |
|
RU2726115C1 |
TRICYCLIC GYRASE INHIBITORS | 2014 |
|
RU2680138C2 |
DERIVATIVES OF 3-[2-(3-ACYLAMINO-2-OXO-2H-PYRIDIN-1-YL)-ACETYLAMINO]-4-OXO-PENTANE ACID AND THEIR APPLICATION AS CASPASE INHIBITORS | 2005 |
|
RU2412936C2 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONА DERIVATIVES AND USING THEM IN TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2570423C2 |
HETEROARYL COMPOUNDS AS IRAK TYPE II INHIBITORS AND THEIR USE | 2019 |
|
RU2810338C2 |
6-MEMBERED HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2016 |
|
RU2683245C1 |
2-PYRAZINONE DERIVATIVES FOR TREATING DISEASES OR CONDITIONS WHERE INHIBITING NEUTROPHIL ELASTASE ACTIVITY IS USEFUL | 2007 |
|
RU2448098C2 |
Authors
Dates
2008-09-10—Published
2003-06-11—Filed